Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction

Introduction: Colorectal cancer (CRC) is the fourth most common cancer worldwide, with high morbidity and mortality rates. In recent years, high-fat diet has been shown to increase CRC morbidity, highlighting the possibility of the application of hypolipidemic drugs for CRC treatment. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuanyuan, Yang, Wenjuan, Jia, Yewei, Ji, Jie, Wu, Liwei, Feng, Jiao, Li, Yan, Cheng, Ziqi, Zhang, Jie, Li, Jingjing, Dai, Weiqi, Xu, Xuanfu, Wu, Jianye, Zhou, Yingqun, Guo, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946110/
https://www.ncbi.nlm.nih.gov/pubmed/36843944
http://dx.doi.org/10.3389/fphar.2023.1081980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946110/
https://www.ncbi.nlm.nih.gov/pubmed/36843944
http://dx.doi.org/10.3389/fphar.2023.1081980

Ejemplares similares